Plus   Neg

Vodafone To Transfer 50% Stake In Cornerstone JV To Vantage Towers

British telecom major Vodafone Group Plc (VOD,VOD.L) Monday said its UK subsidiary, Vodafone Limited, and Telefonica UK Limited agreed for the commercialisation of Cornerstone Telecommunications Infrastructure Limited, the 50:50 owned joint venture company that owns and manages their passive tower infrastructure in the U.K.

Vodafone UK and Telefonica UK have each entered into long-term Master Services Agreements with Cornerstone. The agreements have initial terms of 8 years from 1 January 2021, with three 8-year renewal periods, and which establish Cornerstone as a preferred supplier of new sites for both operators.

Vodafone said it intends to transfer its 50% shareholding in Cornerstone to Vantage Towers in January 2021.

Cornerstone was established in 2012 by Vodafone UK and TEF UK to create and manage a single network of passive infrastructure. The tower infrastructure company in the UK operates about 14,200 macro sites and c.1,400 micro sites. The deal extends Vantage Towers' portfolio to about 82,000.

Vivek Badrinath, Vantage Towers Chief Executive, said, "Cornerstone is exactly the type of high quality grid we like to own: a number one market position, and two strong anchor tenants with network sharing agreements in place for whom we are the preferred supplier."

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The U.S. Food and Drug Administration granted emergency use authorization (EUA) for the first and only clinical T cell-based test for patients to detect the unique T-cell signature specific to SARS-CoV-2, the virus that causes COVID-19. The test confirms recent or prior COVID-19 infection. Developed by Adaptive Biotechnologies, T-Detect COVID Test is a next generation sequencing based (NGS) test. AstraZeneca's one batch of Covid vaccine has been suspended by Austrian health authorities following reports of a death and an illness after receiving vaccination, reports said. The issues were reported in the district clinic of Zwettl in Lower Austria province. The Federal Office for Safety in Health Care in the country said the remaining stocks of the affected AstraZeneca/Oxford Covid-19 vaccine DuPont (DD) announced Monday that it has agreed to acquire Laird Performance Materials from with private equity firm Advent International for $2.3 billion. The company will use existing cash balances for the acquisition. The transaction is expected to close in the third quarter of 2021, subject to regulatory...
Follow RTT